... and for those new to the party, Zantrene is the world's First in Class and Best in Class FTO inhibitor. It has been previously approved in Europe and has numerous historic Phase 2 and 3 trials that prove efficacy and safety. These trials can be used for approval in the US because the program designed and under execution by current leadership has been carefully considered.
So far:
- helps to overcome immunotherapy resistance
- improves cancer elimination of doxorubicin (the most used chemotherapeutic drug in the world)
- reduces heart damage from doxo
- massive impact on extramedullary AML in the clinic
- works on its own and in combo
- and many, many more
General Comments / Chat, page-6055
-
- There are more pages in this discussion • 5,152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
-0.105(5.74%) |
Mkt cap ! $293.8M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.82 | $1.70 | $240.3K | 138.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 270 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |